Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma: A Prospective Single-Arm Study

NCT07881328 is registered in ClinicalTrials.gov with Allied Hospital Faisalabad as lead sponsor.

NCT NCT07881328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma: A Prospective Single-Arm Study
Lead sponsor
Allied Hospital Faisalabad
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
June 30, 2027
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma